On March 7, 2025, the "Start a New Journey, Scale the World, Shine the Future" brand upgrade and relocation ceremony for Qihengxing Bio was grandly held at Building 10, Block A, Liandong U Valley, Beijing Economic and Technological Development Zone. Over a hundred guests from academia, industry, and partner companies gathered to witness this milestone.
New starting point, new look: Industry, academia and research jointly celebrate the relocation
At 8:30 AM, guests arrived at the new address, signed in, and were guided on a tour of the company's R&D labs by the company team. In his opening remarks, Qihengxing General Manager Fu Liangjian reviewed the company's growth story: "From establishing multiple core product R&D technology platforms to expanding CDMO services, we have always been driven by technological innovation. This relocation is not only an upgrade of physical space, but also marks a new strategic phase for Qihengxing, with its focus on 'technology platformization and service specialization.'"
Authoritative empowerment: Industry, academia and research experts discuss the future of the industry
The celebration featured keynote speeches by Professor Zhu Baoli of the Institute of Microbiology, Chinese Academy of Sciences, and Professor Li Yu of Northwestern Polytechnical University. Drawing on cutting-edge international trends, Professor Zhu systematically expounded on the impact of breakthroughs in pan-genomics technology on precision medicine and highly praised Qihengxing's technological development in genetic testing. Professor Li Yu of Northwestern Polytechnical University also shared insights on the experimental technical challenges of enhancer RNA (eRNA) research, resonating deeply with representatives from the research institutions present.
Representatives from industry partners shared their stories of collaboration with Qihengxing. During the presentations, the guests not only reflected on their journey alongside Qihengxing but also envisioned the broad prospects for future collaboration. They stated that as the biotech industry gradually recovers, Qihengxing is leading the way with technological innovation and supported by quality service to continuously expand the depth and breadth of its partnerships. Looking ahead, they expressed confidence that Qihengxing will continue to be driven by innovation and guided by customer needs, continuously launching more competitive products and solutions, and making greater contributions to the advancement of the entire industry.
Hard-core debut: technology matrix demonstrates innovative strength
After the tea break, Dr. Qin Chubin, R&D Director of Qihengxing, and his team introduced Qihengxing's new generation product portfolio: including nucleic acid extraction kits, high-sensitivity PCR/qPCR detection kits, and customized testing services based on NGS technology. This clearly demonstrated the company's technological advantages in standardized and large-scale production.
Working together to innovate: jointly drawing a blueprint for the biotechnology ecosystem
At the end of the event, all guests took a "family photo" to capture this historic moment. This photo not only celebrated the successful relocation and brand upgrade celebration of Qihengxing Bio, but also conveyed their best wishes for Qihengxing's future development. It also symbolized the close connection and unwavering commitment to collaboration between Qihengxing and its partners. Amidst increasingly fierce competition in the biotechnology sector, Qihengxing will leverage its exceptional capabilities in technological innovation, product development, and market expansion to provide clients with higher-quality, more efficient products and services.
About Qihengxing Biotechnology
Founded in 2018, Beijing Qihengxing Biotechnology Co., Ltd. is a national high-tech enterprise with multiple invention patents. Leveraging core technology platforms, including proprietary enzyme engineering platforms, PCR/qPCR systems, nucleic acid extraction platforms, and NGS platforms, the company has developed numerous high-quality products for diverse applications, including molecular biology, NGS applications, and synthetic biology. The company also offers a platform for technical and practical training and customized product development, integrating industry, academia, and research.
